LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,440 pages found matching data breach- Top 10 List: Dangerous Drugs
Jan-12-11 Washington, DC Much has been written about drug side effects, given the fact that ALL drugs have side effects. To that end, the US Food and Drug Administration (FDA) famously holds to its mantra that a drug is acceptable so long as benefits outweigh risk. Translation: all drugs carry risk, to some degree (the same holds true for medical device companies)... - What Will 2011 Bring for Avandia?
Jan-7-11 Seattle, WA Last year was a tough year for Avandia maker GlaxoSmithKline. Between allegations of downplaying Avandia side effects, settling approximately 10,000 Avandia lawsuits and having the drug's use severely restricted by the US Food and Drug Administration (FDA) because of Avandia risks, which include a risk of Avandia heart attack, 2010 was a di... - Is Taser Abuse out of Control?
Jan-7-11 Washington, DC Since 2004, Amnesty International has stated that taser electro-shock weapons are contributing to widespread human rights abuses and that tasers are being used as tools of routine force instead of their original purpose—an alternative to firearms. The organization says that since June 2001, more than 351 individuals in the US... - Air Pollution Still a Factor in Pennsylvania
Dec-31-10 Shippingport, PA There are few areas that know Air Pollution health effects quite like Pittsburgh, Pennsylvania, together with other communities that line the Ohio River. While the air is generally cleaner than it used to be, thanks in part to the Federal Clean Air Act which celebrates its 40th anniversary this year, residents aren't out of the woods y... - Will We Ever Know for Sure if Paxil Causes Paxil Birth Defects?
Dec-29-10 Toronto, Ontario The debate over Paxil side effects as they relate to infants born with heart defects continues to be hotly contested—especially given the need for some women to remain on antidepressants on a consistent basis for depression. So do you stop an antidepressant like Paxil during pregnancy and risk harming the mother? Or do you continue a... - For Yasmin Birth Control Lawsuit, Canadian Lawyers Go to Where the People Are
Dec-24-10 Toronto, Ontario A Canadian class-action lawsuit alleging Yaz side effects and other grievous health issues stemming from Yasmin birth control is being promoted to prospective plaintiffs in a unique, and decidedly modern way—through social networking via Facebook. In attempting to reach out to victims of the problematic contraceptive products, th... - More Lawsuits Filed over ERISA Plan During Recession
Dec-22-10 St. Louis, MO The amount of lawsuits associated with the Employee Retirement Income Security Act ( ERISA ) have increased significantly since the beginning of the recession, the Rockford Register Star reports. According to data from the US District Court, 9,300 lawsuits related to ERISA were filed in the country during the 12-month span that ended o... - Critic Says Avandia Should Be Banned
Dec-20-10 Toronto, ON, Canada A doctor who was critical of the use of the drug Avandia is criticizing Health Canada for allowing the diabetes drug to stay on the market despite Avandia side effects. Much like the US Food and Drug Administration (FDA) response to Avandia risks, Health Canada has advised serious restrictions about whom could be prescribed the medi... - Public Citizen Out Early on Warnings Regarding Januvia
Dec-18-10 Washington, DC It was more than a year ago that the US Food and Drug Administration (FDA) urged a change to the product labeling for Januvia , an oral Type 2 diabetes drug, with regard to various Januvia side effects. However, critics say that the FDA was slow off the mark, given that reports of adverse reactions were coming in soon after Januvia was ap... - FDA to Pull the Plug on Avastin for Metastatic Breast Cancer
Dec-17-10 Washington, DC A cancer drug that was fast-tracked for approval by the US Food and Drug Administration (FDA) in 2008 for the treatment of metastatic breast cancer will have that approval revoked, the agency announced yesterday. The decision follows the recommendation by an expert panel in July that voted 12-1 to reverse the approval of Avastin for meta... - December 15 Most Dangerous Day for California Auto Accidents
Dec-15-10 Los Angeles, CA California Auto Accidents occur anywhere, anytime, but more so in California. And December 15 is the most dangerous day of the year, with more than a 20 percent increase in auto claims compared to the rest of the year. Yes, even more than New Year's Eve. According to a four-year review of claims data from Allstate Insurance, the numb... - FDA Considering New Diet Drug that Contains Wellbutrin
Dec-8-10 Washington, DC An FDA advisory committee has voted 13-7 in favor of approving a new diet drug designed to aid weight loss. Made by Orexigen, the drug, if approved on January 31, 2011, will be marketed under the name Contrave. The diet pill is a combination of two drugs which have been on the market for roughly 25 years – Bupropion – als... - DePuy Warned for Three Years About Defective Hips
Dec-5-10 Adelaide, Australia Issues surrounding DePuy Hip Replacement are not limited to the US. In fact, concern over the allegedly defective medical devices in Australia appears to pre-date that of North Americans. Even as the DePuy replacement hips were pulled from the Australian market before they disappeared in the US, it has been reported that the makers... - Google Under Scrutiny by European Commission for Alleged Antitrust Activity
Nov-30-10 BRUSSELS Google, the giant internet search engine, has come under the scrutiny of the European Commission (EC), which has just announced an antitrust investigation amidst allegations Google has abused its dominance in the global online search arena. The New York Times is reporting this morning that Google is alleged to have provided "preferential... - Meridia Is Off the Market, but Consumers Could Still Be at Risk
Nov-23-10 Rockville, MD Although Meridia has been pulled from the market due to the risk of serious Meridia side effects, consumers could still be exposed to Meridia-related side effects. Meridia is known generically as sibutramine, and the US Food and Drug Administration (FDA) has created a list of weight loss products that contain sibutramine and could therefo... - Did Heparin Mix-Up with Insulin Contribute to Infant's Death?
Nov-17-10 Saskatoon, Saskatchewan Not long ago actor Dennis Quaid made headlines after his infant children were given an adult dose of heparin in the hospital, rather than the formulation meant for infants. An investigation determined the labels of the two formulations were too similar. Well, it has happened again—sort of. This time, in Canada. And this time,... - Exposure to Depakote During Pregnancy Has Negative Impact on Academics
Nov-16-10 Stockholm, Sweden A Swedish study published recently in Epilepsia has found that taking multiple anti-epilepsy drugs like Depakote during pregnancy can have a negative impact on the academic abilities of the children, Businessweek reports. The study examined women with epilepsy who gave birth between 1973 and 1986, looking at both the anti-epile... - Update of Swedish Study Upholds Concern for SSRI Birth Defects
Nov-13-10 Linkoping, Sweden Swedish research on maternal use of antidepressants in pregnancy continues to bolster existing concerns about SSRI birth defects , according to a recent issue of Obesity, Fitness & Wellness Week (OFWW). "Concerns have been expressed about possible adverse effects of the use of antidepressant medication during pregnancy, including... - Will New Potential Benefit Breathe New Life into Avandia?
Nov-4-10 Vancouver, BC In what will likely serve to only complicate the continuing debate over the safety and efficacy of Avandia , new research is suggesting that the class of diabetes drugs to which Avandia belongs may both prevent, and contain lung cancer. The findings were presented yesterday (November 2nd) at the annual meeting of the American College of Ch... - Will We Start Hearing of Bydureon Acute Pancreatitis One Day?
Oct-23-10 Washington, DC The manufacturers of Byetta continue to pursue their quest to bring a new, once-weekly injectable suspension to market. Known as Bydureon exenatide extended-release, the product provides much promise for diabetes patients who tire of daily injections, and is expected to do well. The prospect of having to undertake an injection once per w...